ArticleScientific reports2026
Fixel-based analysis reveals whole-brain white matter microstructural alterations in axial spondyloarthritis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Axial spondyloarthritis (axSpA) is a chronic inflammatory disorder that may influence the central nervous system through systemic inflammation. While functional brain alterations have been reported, white matter microstructural changes remain poorly understood. This study investigated white matter alterations in axSpA using fixel-based analysis (FBA). Thirty-nine axSpA patients (mean age 28.5 ± 6.3 years) and 41 healthy controls (29.1 ± 5.8 years) underwent diffusion MRI. FBA assessed fiber density (FD), fiber-bundle cross-section (FC), and combined fiber density and cross-section (FDC) across the whole brain. Group differences were analyzed controlling for age, sex, and education. Clinical correlations were assessed with False Discovery Rate (FDR) correction. Compared to controls, axSpA patients showed significantly increased FC in the left external capsule (EC) and increased FDC in the right EC and right uncinate fasciculus (UF) (family-wise error corrected P < 0.05). No significant FD alterations were observed. In exploratory analyses, left EC FC showed a nominal positive correlation with physical function scores (Rho = 0.21, uncorrected P = 0.037), but this association did not survive FDR correction (adjusted P > 0.05). axSpA involves asymmetric white matter remodeling with increased bundle cross-section in corticostriatal and limbic pathways. These findings likely reflect active neuroinflammatory processes—such as maladaptive structural remodeling or compensatory hypertrophy—likely representing a distinct mechanism from the atrophy observed in later stages of neurodegeneration. FBA provides sensitive metrics for detecting these subtle macrostructural alterations in axSpA.Registry: chictr.org.cn, TRN: ChiCTR2500111024, Registration date: 23rd October 2025.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.